Paul Tudor Jones's INSM Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 1,703 shares of Insmed Incorporated (INSM) worth $245,249, representing 0.00% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in INSM, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2025, adding 122,124 shares. Largest reduction occurred in Q3 2025, reducing 132,307 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Insmed Incorporated (INSM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Insmed Incorporated (INSM) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2015 | +27,175 | New Buy | 27,175 | $20.79 |
| Q2 2015 | -27,175 | Sold Out | 27,175 | $0.00 |
| Q3 2015 | +18,238 | New Buy | 18,238 | $18.59 |
| Q4 2015 | -18,238 | Sold Out | 18,238 | $0.00 |
| Q1 2016 | +21,553 | New Buy | 21,553 | $12.67 |
| Q2 2016 | +6,610 | Add 30.67% | 28,163 | $9.87 |
| Q3 2016 | -5,127 | Reduce 18.20% | 23,036 | $14.50 |
| Q4 2016 | -149 | Reduce 0.65% | 22,887 | $13.24 |
| Q1 2017 | -7,220 | Reduce 31.55% | 15,667 | $17.49 |
| Q2 2017 | +5,955 | Add 38.01% | 21,622 | $17.16 |
| Q3 2017 | +14,047 | Add 64.97% | 35,669 | $31.20 |
| Q4 2017 | -26,647 | Reduce 74.71% | 9,022 | $31.15 |
| Q1 2018 | +6,044 | Add 66.99% | 15,066 | $22.50 |
| Q2 2018 | -15,066 | Sold Out | 15,066 | $0.00 |
| Q1 2019 | +19,029 | New Buy | 19,029 | $29.06 |
| Q2 2019 | +31,432 | Add 165.18% | 50,461 | $25.60 |
| Q3 2019 | -33,068 | Reduce 65.53% | 17,393 | $17.65 |
| Q4 2019 | +2,026 | Add 11.65% | 19,419 | $23.89 |
| Q1 2020 | -19,419 | Sold Out | 19,419 | $0.00 |
| Q4 2021 | +38,371 | New Buy | 38,371 | $27.23 |
| Q1 2022 | +6,999 | Add 18.24% | 45,370 | $23.50 |
| Q2 2022 | +16,664 | Add 36.73% | 62,034 | $19.71 |
| Q3 2022 | +157 | Add 0.25% | 62,191 | $21.55 |
| Q4 2022 | +10,790 | Add 17.35% | 72,981 | $0.02 |
| Q1 2023 | -3,723 | Reduce 5.10% | 69,258 | $0.02 |
| Q2 2023 | -30,180 | Reduce 43.58% | 39,078 | $21.10 |
| Q3 2023 | -13,661 | Reduce 34.96% | 25,417 | $25.25 |
| Q4 2023 | -2,373 | Reduce 9.34% | 23,044 | $30.99 |
| Q1 2024 | -23,044 | Sold Out | 23,044 | $0.00 |
| Q3 2024 | +11,886 | New Buy | 11,886 | $73.00 |
| Q4 2024 | -11,886 | Sold Out | 11,886 | $0.00 |
| Q2 2025 | +134,010 | New Buy | 134,010 | $100.64 |
| Q3 2025 | -132,307 | Reduce 98.73% | 1,703 | $144.01 |
Paul Tudor Jones's Insmed Incorporated Investment FAQs
Paul Tudor Jones first purchased Insmed Incorporated (INSM) in Q1 2015, acquiring 27,175 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Insmed Incorporated (INSM) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to Insmed Incorporated (INSM) was in Q2 2025, adding 134,010 shares worth $13.49 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 1,703 shares of Insmed Incorporated (INSM), valued at approximately $245,249. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Insmed Incorporated (INSM) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in Insmed Incorporated (INSM) was 134,010 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.